F1000Research (Jun 2020)

Pilot study for the evaluation and adaptation of a Four Item-Acne-Scar Risk Assessment Tool (4-ASRAT): a resource to estimate the risk of acne-induced scars [version 1; peer review: 2 approved]

  • Jorge Estrella Porter,
  • Mikaela Camacho,
  • María Isabel Viteri,
  • Katherine Aguilar,
  • Drifa Belhadi,
  • Vincenzo Bettoli,
  • Anita del Rocío Buestán,
  • Brigitte Dréno,
  • Pablo Endara,
  • Alison Layton,
  • Nelly Machado,
  • Rosa Mateus,
  • Jerry Tan,
  • Enrique Terán,
  • Paola Yépez,
  • Jonathan Guillemot

DOI
https://doi.org/10.12688/f1000research.23737.1
Journal volume & issue
Vol. 9

Abstract

Read online

Background: Acne-induced scarring is associated with a similar burden as acne, i.e. diminished quality of life, and may be avoided if patients receive appropriate and timely acne treatment. In 2017, a four item-Acne-Scar Risk Assessment Tool (4-ASRAT) was designed by Tan et al. to categorise patients with acne into lower-risk or higher-risk for acne scarring. Its applicability outside the initial study population (France, Brazil and United States) remains to be determined. Methods: A study protocol was developed to create a systematic approach for validating and adapting 4-ASRAT to different populations, Ecuador in this case. The protocol was reviewed by 11 local and international dermatologists and pilot-tested in an Ecuadorian population using a sample of 10 participants who currently had or had had acne. Feedback from the pilot study was used to improve the study protocol. The results of the pilot study are included here, and the final study protocol is available as extended data. Results: The protocol proved to be applicable. Images taken of participants were a valuable resource for dermatological evaluation about the presence or absence of acne scars. Tangential light is necessary for this evaluation. Although dermatological assessments varied, we concluded that assessment by three local dermatologists for each participant was adequate for reaching a consensus on the presence or absence of acne scars. Conclusions: Considering the morbidity related to acne and acne scars, tools designed as prevention that alert patients about risk of developing scarring are necessary. The proposed protocol shows a feasible way of validating and adapting 4-ASRAT to different populations.